NCT07313839

Brief Summary

Vaginal vault closure after laparoscopic or robotic hysterectomy may be associated with postoperative complications such as vaginal cuff dehiscence, infection, and bleeding. The optimal suture material and technique for laparoscopic colporrhaphy, particularly in patients undergoing surgery for gynecologic malignancies, remain controversial. The BI-SURE trial is a multicenter, randomized controlled study designed to compare double-layer self-locking sutures versus double-layer traditional Polyglactin 910 sutures for laparoscopic vaginal vault closure after hysterectomy. The study aims to evaluate postoperative effectiveness and safety within three months after surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
310

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Oct 2025

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Oct 2025Jan 2027

Study Start

First participant enrolled

October 7, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 2, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

1.2 years

First QC Date

December 18, 2025

Last Update Submit

December 18, 2025

Conditions

Keywords

Laparoscopic hysterectomyVaginal vault closureColporrhaphySelf-locking sutureBarbed suturePolyglactin 910Gynecologic oncologyPostoperative complicationsRandomized controlled trial

Outcome Measures

Primary Outcomes (3)

  • Vaginal cuff dehiscence rate

    Proportion of participants experiencing vaginal cuff dehiscence requiring surgical reintervention after laparoscopic hysterectomy.

    Within 3 months after surgery

  • Vaginal cuff infection rate

    Proportion of participants developing vaginal cuff infection, defined as abnormal vaginal discharge with or without fever, leukocytosis, and/or local tenderness, requiring antibiotic therapy.

    Within 3 months after surgery

  • Postoperative bleeding rate

    Proportion of participants experiencing postoperative vaginal cuff bleeding requiring hemostatic treatment.

    Within 3 months after surgery

Secondary Outcomes (2)

  • Postoperative pain intensity

    At 1 month and 3 months after surgery

  • Early postoperative composite complication rate

    Within 1 month after surgery

Study Arms (2)

Self-Locking Suture Group

EXPERIMENTAL

Participants randomized to this arm will undergo laparoscopic vaginal vault closure after hysterectomy using a double-layer continuous suturing technique performed with a self-locking (barbed) suture, according to current clinical practice.

Procedure: Double-Layer Vaginal Vault Closure with Self-Locking Suture

Traditional Suture Group

ACTIVE COMPARATOR

Participants randomized to this arm will undergo laparoscopic vaginal vault closure after hysterectomy using a double-layer continuous suturing technique performed with traditional braided Polyglactin 910 suture, according to current clinical practice.

Procedure: Double-Layer Vaginal Vault Closure with Polyglactin 910

Interventions

Laparoscopic vaginal vault closure performed using a double-layer continuous suturing technique with a self-locking (barbed) suture following hysterectomy.

Self-Locking Suture Group

Laparoscopic vaginal vault closure performed using a double-layer continuous suturing technique with traditional braided Polyglactin 910 suture following hysterectomy.

Traditional Suture Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing laparoscopic or robotically assisted hysterectomy for gynecologic malignant disease
  • Age ≥ 18 years
  • Ability to provide written informed consent

You may not qualify if:

  • Laparotomic or vaginal hysterectomy
  • Contraindication to laparoscopic vaginal vault closure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Department of Medicine and Surgery, University Hospital of Parma

Parma, Italy, 43125, Italy

RECRUITING

Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Bologna, Italy

NOT YET RECRUITING

Department of Obstetrics and Gynecology, Ospedale Santa Croce e Carle, Cuneo, Italy.

Cuneo, Italy

RECRUITING

Department of Gynecologic Oncology. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Milan, Italy

NOT YET RECRUITING

Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Udine, Italy

NOT YET RECRUITING

MeSH Terms

Conditions

Postoperative Complications

Interventions

Polyglactin 910

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PolyestersPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Central Study Contacts

Vito Andrea Capozzi

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a multicenter, pragmatic, randomized controlled trial with a parallel assignment design. Eligible patients will be randomized in a 1:1 ratio to receive either double-layer self-locking sutures or double-layer traditional Polyglactin 910 sutures for laparoscopic vaginal vault closure following hysterectomy for gynecologic malignancy. The study is triple-blinded, with participants, outcome assessors, and statisticians masked to treatment allocation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vito Andrea Capozzi, M.D. Department of Medicine and Surgery University Hospital of Parma, Parma, Italy

Study Record Dates

First Submitted

December 18, 2025

First Posted

January 2, 2026

Study Start

October 7, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

January 2, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the study is conducted within a hospital-based academic setting and no data repository has been designated for public data release. Data will be stored securely at the sponsor institution and will be accessible only to authorized study personnel in compliance with applicable privacy regulations.

Locations